Insulet
PODD
598 hedge funds and large institutions have $14.1B invested in Insulet in 2024 Q2 according to their latest regulatory filings, with 110 funds opening new positions, 239 increasing their positions, 194 reducing their positions, and 67 closing their positions.
167% more funds holding in top 10
Funds holding in top 10: 3 → 8 (+5)
64% more first-time investments, than exits
New positions opened: 110 | Existing positions closed: 67
23% more repeat investments, than reductions
Existing positions increased: 239 | Existing positions reduced: 194
18% more capital invested
Capital invested by funds: $12B → $14.1B (+$2.11B)
6% more funds holding
Funds holding: 563 → 598 (+35)
0.23% less ownership
Funds ownership: 100.15% → 99.92% (-0.23%)
42% less call options, than puts
Call options by funds: $122M | Put options by funds: $210M
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$173M |
| 2 |
DCP
D1 Capital Partners
New York
|
-$131M |
| 3 |
SPC
Slate Path Capital
New York
|
-$76.2M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$74.1M |
| 5 |
Barclays
London,
United Kingdom
|
-$52.3M |
PODD Hedge Fund Activity: Q2 2024 in Review
598 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q2 2024, worth a combined $14.1B — up 18% from $12B a quarter earlier.
Buyers outnumbered sellers: 110 funds opened new PODD positions and 67 closed out — a net gain of 43 holders — while 239 added to existing stakes and 194 trimmed.
The largest buyer was Fidelity International, adding an estimated $123M. The largest seller was Wellington Management Group, cutting an estimated $173M.
- 598 institutional investors held Insulet (PODD) as of Q2 2024, up from 563 in Q1 2024.
- Funds reported $14.1B of Insulet stock for Q2 2024, up 18% quarter-over-quarter.
- 110 funds opened new Insulet positions in Q2 2024 and 67 closed out, a net change of +43 holders.
- The largest Insulet buyer in Q2 2024 was Fidelity International, an estimated $123M added.
- The largest Insulet seller in Q2 2024 was Wellington Management Group, an estimated $173M sold.
Based on aggregated 13F filings for Q2 2024.